|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of Revenues | |||||
| Gross Profit | |||||
| Operating Expenses | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment of goodwill | |||||
| Acquisition-related costs | |||||
| Transaction costs | |||||
| Impairment of goodwill and intangibles | |||||
| Merger-related transaction costs | |||||
| Impairment of intangible assets | |||||
| Merger and acquisition transaction costs | |||||
| Amortization of intangible assets | |||||
| Total Operating Expenses | |||||
| Loss from Operations | |||||
| Interest expense, net | |||||
| Loss on exchange of debt for equity | |||||
| Other (Expense) Income | |||||
| Interest expense, net | |||||
| Interest income | |||||
| Amortization of deferred loan costs | |||||
| Loss on conversion of note receivable to equity investment | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value of Damon investment and related warrants | |||||
| Provision for expected credit losses on convertible note investment | |||||
| Change in fair value of convertible notes payable | |||||
| Change in fair value of equity securities | |||||
| Change in fair value of warrant liability | |||||
| Change in fair value of JV obligation | |||||
| Other income/(expense), net | |||||
| Warrant inducement expense | |||||
| Unrealized loss on equity securities | |||||
| Warrant issuance expense | |||||
| Other income, net | |||||
| Total Other (Expense) Income | |||||
| Loss from Continuing Operations Before Income Taxes | |||||
| Income tax benefit (provision) | |||||
| Net Loss from Continuing Operations, net of tax | |||||
| Loss from discontinued operations, net of tax | |||||
| Net Loss | |||||
| Net (income) loss attributable to noncontrolling interest | |||||
| Net Loss Attributable to XTI Aerospace, Inc. | |||||
| Accretion of preferred stock | |||||
| Series 7 Preferred Stock | |||||
| Series 8 Preferred Stock | |||||
| Deemed dividend for the modification related to Series 8 Preferred Stock | |||||
| Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock | |||||
| Amortization premium- modification related to Series 8 Preferred Stock | |||||
| Less: Preferred stock return and dividend | |||||
| Less: Preferred stock dividends | |||||
| Less: Deemed dividends | |||||
| Net Loss Attributable to Common Stockholders | |||||
| Net Loss Per Share – Basic and Diluted: | |||||
| Continuing operations (in Dollars per share) | |||||
| Net loss per share – diluted Continuing operations (in Dollars per share) | |||||
| Discontinued operations (in Dollars per share) | |||||
| Net loss per share – diluted Discontinued operations (in Dollars per share) | |||||
| Net loss per share (in Dollars per share) | |||||
| Net loss per share – diluted (in Dollars per share) | |||||
| Weighted Average Shares Outstanding, Basic (in Shares) | |||||
| Weighted Average Shares Outstanding, Diluted (in Shares) | |||||
Loading...